Filtered By:
Management: Partnerships

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 14705 results found since Jan 2013.

The 2014 China meeting of the International Society for Vascular Surgery.
Abstract The 2014 meeting of the International Society for Vascular Surgery (ISVS) was held in Guangzhou, China, in conjunction with the fifth annual Wang Zhong-Gao's Vascular Forum, the eighth annual China Southern Endovascular Congress, and the third annual Straits Vascular Forum. Keynote addresses were given by Professors Christos Liapis, Wang Zhong-Gao, and Wang Shen-Ming. President Liapis presented the first ISVS Lifetime Achievement Award to Professor Wang Zhong-Gao for his multi-decade accomplishments establishing Vascular Surgery as a specialty in China. Faculty presentations were made in plenary sessions ...
Source: Vascular - August 20, 2014 Category: Surgery Authors: Dardik A, Ouriel K, Wang J, Liapis C Tags: Vascular Source Type: research

Vascular Surgery in Ethiopia: Result of Twinning Partnership in Developing Vascular Care
In Sub-Saharan Africa, the field of vascular surgery is relatively new. Cardiovascular diseases and other noncommunicable diseases account for>70% of global mortality; moreover, 5 billion people have no access to basic and emergency surgical care. Since 2016, the Division of Vascular Surgery of the University of Wisconsin and Tikur Anbessa Specialized Hospital of Addis Ababa University in Ethiopia developed a partnership whereby a vascular surgery care and fellowship training program was initiated.
Source: Journal of Vascular Surgery - August 21, 2019 Category: Surgery Authors: Nebyou S. Abebe, Yoseph Z. Semma, Ferron Getachew, Jon Matsumura, Girma Tefera Tags: Abstract from the 2019 Midwestern Vascular Surgical Society Annual Meeting Source Type: research

Partnerships between podiatrists and vascular surgeons in building effective wound care centers
This practice memo, a collaborative effort between the Young Physicians' Program of the American Podiatric Medical Association and the Young Surgeons Committee of the Society for Vascular Surgery, is intended to aid podiatrists and vascular surgeons in the early years of their respective careers, especially those involved in the care of patients with chronic wounds. During these formative years, learning how to successfully establish an interprofessional partnership is crucial to provide the best possible care to this important population of patients.
Source: Journal of Vascular Surgery - August 22, 2017 Category: Surgery Authors: Venita Chandra, Natalia O. Glebova, Nichol L. Salvo, Timothy Wu Tags: Society for Vascular Surgery document Source Type: research

The Impact of Surgical Care Improvement Project Measures on In-Hospital Outcomes following Elective Vascular Procedures
As part of the Surgical Care Improvement Project (SCIP), a national quality partnership of organizations including the Centers for Medicare and Medicaid Services and the Centers for Disease Control and Prevention implemented several perioperative guidelines regarding antibiotic, venous thromboembolism (VTE), and beta-blocker prophylaxis for surgical patients. We evaluated the effect of SCIP on in-hospital surgical site infections (SSI), graft infections, VTE, myocardial infarctions (MIs), cardiac complications, mortality, and length of stay following elective major vascular surgery.
Source: Annals of Vascular Surgery - August 9, 2016 Category: Surgery Authors: Kenneth R. Nakazawa, Natalia N. Egorova, John R. Power, Peter L. Faries, Ageliki G. Vouyouka Tags: Vascular & Endovascular Surgery Society Source Type: research

They sold their company to Boston Scientific and then reacquired the technology years later – the unique story of NuCryo Vascular
NuCryo Vascular GM      Kevin Beedon Welcome to the Medsider interview series, a special new feature at MassDevice, which will appear regularly. All interviews are conducted by Scott Nelson, Founder of Medsider and Partnership Lead at Touch Surgery. We hope you enjoy them! Because of diminishing margins, a lot of major medical device companies continue to add products to their sales bag in hopes of meeting top-line revenue goals. But successfully selling the entire bag can be challenging. When the bag gets too big, a typical sales force will usually focus only on products that generate the most revenue. So what about th...
Source: Mass Device - February 26, 2016 Category: Medical Equipment Authors: Scott Nelson Tags: Business/Financial News NuCryo Vascular Source Type: news

Humacyte launches Phase II vascular trauma Humacyl vessel trial
Humacyte said yesterday it launched a U.S. Phase II trial of its Humacyl investigational human acellular vessel exploring the systems’ use for vascular replacement or reconstruction in patients with life or limb-threatening vascular trauma. The Research Triangle Park, N.C.-based company said it hopes to enroll 40 adult patients at six U.S. sites for the trial, with patient monitoring extending out to 24 months. “As a world leader in trauma research, we are constantly exploring new and innovative approaches to treating life threatening injuries. We look forward to evaluating this bioengineered blood vessel in th...
Source: Mass Device - October 26, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Featured Vascular Humacyte Source Type: news

QT Vascular raises $14m
QT Vascular said this week it inked a private placement deal with Gem Global Yield Fund for up to $14.3 million (SGD $20 million) over the next 30 months. In the funding agreement, Singapore-based QT Vascular will receive up to $7.2 million (SGD $10 million) over the next 30 months, with an option for an additional $7.2 million on identical terms to the original agreement. The option is available for a period of 6 months, the company said. Funds are slated to support repaying existing debt, improve cash flow and increase production to support its non-drug coated Chocolate PTA products. “This agreement with GEM Globa...
Source: Mass Device - March 22, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Catheters QT Vascular Source Type: news

Patient-reported outcomes in hemodialysis vascular access: A call to action
J Vasc Access. 2021 May 25:11297298211018295. doi: 10.1177/11297298211018295. Online ahead of print.ABSTRACTWhile access-related dysfunction is a clear driver of clinical outcomes and costs, the full impact of vascular access dysfunction on patient experience and quality of life is not fully characterized in the literature. One way to more comprehensively characterize the patient experience from the patient perspective is through patient reported outcomes (PROs). However, the limited implementation of PROs in clinical trials, patient registries, quality measurement, and other research settings has significantly constrained...
Source: The Journal of Vascular Access - May 25, 2021 Category: Surgery Authors: Karen Woo Robert Fuld Amanda Grandinetti Jeffrey Lawson Terry Litchfield Mark Ohan John Devin Peipert Matthew B Rivara Glenda Roberts Prabir Roy-Chaudhury Margo Underwood Robert J Nordyke Source Type: research

Gecko Biomedical wins CE Mark for Setalum vascular sealant
Gecko Biomedical said today it won CE Mark approval in the European Union for its Setalum Sealant designed for use during vascular surgery. The Paris-based company said Setalum is a biocompatible, bioresorbable sealant designed as an add-on to sutures, and is usable in wet and dynamic environments and activated using a light activation pen. The CE Mark approval marks the 1st regulatory win for Gecko Biomedical’s Setalum, the company said. “We are delighted to receive the CE Mark for our 1st product, Setalum sealant, as this will allow us to bring new and innovative solutions to the market to improve patient car...
Source: Mass Device - September 11, 2017 Category: Medical Devices Authors: Fink Densford Tags: Regulatory/Compliance Surgical Vascular Gecko Biomedical Source Type: news

Vascular access hands-on training for young nephrologists: The fellows' experience of the N-PATH project REVAC module
J Vasc Access. 2023 Jun 19:11297298231180325. doi: 10.1177/11297298231180325. Online ahead of print.ABSTRACTChronic kidney disease is a major public health problem, as population studies record a prevalence of 7.2% in individuals over 30 years and is expected to increase in the future. Many of them will end up undergoing hemodialysis treatment, and vascular access is not only an essential requirement for the technique, but also a determining factor in their prognosis; for all these reasons, every nephrologist should have both theoretical and practical knowledge of vascular access; however, the practical training is general...
Source: The Journal of Vascular Access - June 20, 2023 Category: Surgery Authors: Raquel Barba Teba Lide L ópez Arsuaga Louis Firket Filipa Ferreira Wouter Moest Sinead Stoneman Georgia Andriana Georgopoulou Adamantia Bratsiakou Maurizio Gallieni Source Type: research

Phillips Azurion with FlexArm for Enhanced Image-Guided Therapy: Interview with Dr. Barry Katzen of Miami Cardiac and Vascular Institute
Phillips recently announced the release of an enhancement to its Azurion imaging system – the FlexArm. Developed in partnership with the Miami Cardiac & Vascular Institute, the technology allows a clinician to image a patient from every possibl...
Source: Medgadget - March 25, 2019 Category: Medical Devices Authors: Conn Hastings Tags: Cardiac Surgery Cardiology Exclusive Radiology Thoracic Surgery Vascular Surgery Source Type: blogs

FDA clears Corindus Vascular Robotics CorPath for peripheral interventions
Corindus Vascular Robotics (NYSE:CVRS) said today that it won FDA 510(k) clearance for its robotic-assisted CorPath system for peripheral interventions, a year after launching a clinical trial. The clearance was based on the 20-patient Rapid trial, a prospective, single-arm, single-center study designed to look at the safety and effectiveness of the CorPath device in peripheral artery disease patients with lower-extremity blockages. “For the past 2 years, I have been successfully treating my coronary patients with robotic precision while protecting my staff and me from the hazards of radiation exposure in the c...
Source: Mass Device - March 29, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Regulatory/Compliance Robot-Assisted Surgery Corindus Vascular Robotics Peripheral Artery Disease Source Type: news